Cargando…
SHP2 phosphatase as a novel therapeutic target for melanoma treatment
Melanoma ranks among the most aggressive and deadly human cancers. Although a number of targeted therapies are available, they are effective only in a subset of patients and the emergence of drug resistance often reduces durable responses. Thus there is an urgent need to identify new therapeutic tar...
Autores principales: | Zhang, Ruo-Yu, Yu, Zhi-Hong, Zeng, Lifan, Zhang, Sheng, Bai, Yunpeng, Miao, Jinmin, Chen, Lan, Xie, Jingwu, Zhang, Zhong-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342016/ https://www.ncbi.nlm.nih.gov/pubmed/27650545 http://dx.doi.org/10.18632/oncotarget.12074 |
Ejemplares similares
-
Therapeutic Potential of Targeting
the Oncogenic SHP2
Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014) -
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity
por: Miao, Jinmin, et al.
Publicado: (2023) -
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
por: Chen, Hao, et al.
Publicado: (2020) -
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated
SHP2 Mutations
por: Yu, Zhi-Hong, et al.
Publicado: (2014) -
The Protein Tyrosine Phosphatase, Shp2, Positively Contributes to FLT3-ITD-Induced Hematopoietic Progenitor Hyperproliferation and Malignant Disease In Vivo
por: Nabinger, Sarah C., et al.
Publicado: (2012)